Sun Life Financial Inc Incyte Corp Transaction History

Sun Life Financial Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$79.87 - $87.53 $9,025 - $9,890	-113 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$76.02 - $100.5 $152 - $201	2 Added 1.8%	113 $9,000
Q3 2020 Nov 09, 2020	BUY	$85.07 - $109.69 $340 - $438	4 Added 3.74%	111 $10,000
Q1 2020 May 12, 2020	BUY	$63.18 - $85.97 $126 - $171	2 Added 1.9%	107 $8,000
Q4 2019 Feb 10, 2020	SELL	$73.04 - $95.72 $2,994 - $3,924	-41 Reduced 28.08%	105 $9,000
Q3 2019 Nov 13, 2019	BUY	$72.82 - $86.52 $72 - $86	1 Added 0.69%	146 $11,000
Q2 2019 Aug 08, 2019	SELL	$73.52 - $88.7 $11,542 - $13,925	-157 Reduced 51.99%	145 $12,000
Q1 2019 May 14, 2019	SELL	$63.56 - $88.17 $11,758 - $16,311	-185 Reduced 37.99%	302 $26,000
Q4 2018 Feb 06, 2019	BUY	$58.5 - $69.94 $292 - $349	5 Added 1.04%	487 $31,000
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $370 - $445	6 Added 1.26%	482 $33,000
Q2 2018 Aug 09, 2018	BUY	$60.85 - $83.98 $24,887 - $34,347	409 Added 610.45%	476 $32,000
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $26,163 - $31,808	-315 Reduced 82.46%	67 $0
Q4 2017 Feb 13, 2018	SELL	$93.56 - $116.6 $81,865 - $102,025	-875 Reduced 69.61%	382 $36,000
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $137,201 - $173,805	1,257	1,257 $147,000

706

189M

909K

489K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Sun Life Financial Inc with notifications on news.